Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wouter Jukema

Showing results (81-90 of 927) with videos related to

Pageof 93
Sort By:
European Journal of Pharmacology|May 20, 2015
Innovative pharmaceutical interventions in cardiovascular disease: Focusing on the contribution of non-HDL-C/LDL-C-lowering versus HDL-C-raising: A systematic review and meta-analysis of relevant preclinical studies and clinical trialsSusan Kühnast, Marta Fiocco, José W A van der Hoorn, et al.
The American Journal of Cardiology|June 6, 2017
Prognostic Implications of Left Ventricular Global Longitudinal Strain in Predialysis and Dialysis PatientsLiselotte C R Hensen, Kathleen Goossens, Victoria Delgado, et al.
Atherosclerosis|December 7, 2010
Atorvastatin inhibits plaque development and adventitial neovascularization in ApoE deficient mice independent of plasma cholesterol levelsIlze Bot, J Wouter Jukema, Inge M Lankhuizen, et al.
Journal of the American Heart Association|November 19, 2021
Diet-Derived Antioxidants Do Not Decrease Risk of Ischemic Stroke: A Mendelian Randomization Study in 1 Million PeopleLeon G Martens, Jiao Luo, Ko Willems van Dijk, et al.
Archives of Internal Medicine|June 30, 2010
Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participantsKausik K Ray, Sreenivasa Rao Kondapally Seshasai, Sebhat Erqou, et al.
Journal of Cellular and Molecular Medicine|February 6, 2010
Epigenetics in atherosclerosis and inflammationRutger J Wierda, Sacha B Geutskens, J Wouter Jukema, et al.
BMC Cancer|February 2, 2023
Cardiac and obstetric outcomes of pregnancies for women after cardiotoxic therapy in childhood: a single center observational studyJulius C Heemelaar, Steffie Heemelaar, Svenja N Hertel, et al.
Journal of Lipid Research|March 15, 2025
Potential causal evidence for an ApoB-independent and HDL-related risk profile associated with coronary artery diseaseLinjun Ao, Diana van Heemst, J Wouter Jukema, et al.
European Journal of Preventive Cardiology|November 13, 2022
Setting your clock: associations between timing of objective physical activity and cardiovascular disease risk in the general populationGali Albalak, Marjon Stijntjes, David van Bodegom, et al.
Diabetes Care|August 17, 2013
Stratified patient-centered care in type 2 diabetes: a cluster-randomized, controlled clinical trial of effectiveness and cost-effectivenessAnnabelle S Slingerland, William H Herman, William K Redekop, et al.
Pageof 93

Showing results (81-90 of 927) with videos related to

Sort By:
Pageof 93
European Journal of Pharmacology|May 20, 2015
Innovative pharmaceutical interventions in cardiovascular disease: Focusing on the contribution of non-HDL-C/LDL-C-lowering versus HDL-C-raising: A systematic review and meta-analysis of relevant preclinical studies and clinical trialsSusan Kühnast, Marta Fiocco, José W A van der Hoorn, et al.
The American Journal of Cardiology|June 6, 2017
Prognostic Implications of Left Ventricular Global Longitudinal Strain in Predialysis and Dialysis PatientsLiselotte C R Hensen, Kathleen Goossens, Victoria Delgado, et al.
Atherosclerosis|December 7, 2010
Atorvastatin inhibits plaque development and adventitial neovascularization in ApoE deficient mice independent of plasma cholesterol levelsIlze Bot, J Wouter Jukema, Inge M Lankhuizen, et al.
Journal of the American Heart Association|November 19, 2021
Diet-Derived Antioxidants Do Not Decrease Risk of Ischemic Stroke: A Mendelian Randomization Study in 1 Million PeopleLeon G Martens, Jiao Luo, Ko Willems van Dijk, et al.
Archives of Internal Medicine|June 30, 2010
Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participantsKausik K Ray, Sreenivasa Rao Kondapally Seshasai, Sebhat Erqou, et al.
Journal of Cellular and Molecular Medicine|February 6, 2010
Epigenetics in atherosclerosis and inflammationRutger J Wierda, Sacha B Geutskens, J Wouter Jukema, et al.
BMC Cancer|February 2, 2023
Cardiac and obstetric outcomes of pregnancies for women after cardiotoxic therapy in childhood: a single center observational studyJulius C Heemelaar, Steffie Heemelaar, Svenja N Hertel, et al.
Journal of Lipid Research|March 15, 2025
Potential causal evidence for an ApoB-independent and HDL-related risk profile associated with coronary artery diseaseLinjun Ao, Diana van Heemst, J Wouter Jukema, et al.
European Journal of Preventive Cardiology|November 13, 2022
Setting your clock: associations between timing of objective physical activity and cardiovascular disease risk in the general populationGali Albalak, Marjon Stijntjes, David van Bodegom, et al.
Diabetes Care|August 17, 2013
Stratified patient-centered care in type 2 diabetes: a cluster-randomized, controlled clinical trial of effectiveness and cost-effectivenessAnnabelle S Slingerland, William H Herman, William K Redekop, et al.
Pageof 93